Combination therapy of ulinastatin and Tα1 reduce 28d and 90d mortality rates and organ damages in sepsis patients while the effect of the medication alone use was not satisfactory (Han et al., 2015; Liu et al., 2017). Here, TAAR1 is linked to Sepsis.